Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rheumatoid Arthritis(RA)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06791980
What this trial is testing

Integrated Care Approach for Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis (RA)
Dalin Tzu Chi General Hospital 67
Not applicableStudy completedNCT01557322
What this trial is testing

Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Pfizer 1,754
Testing effectiveness (Phase 2)Study completedNCT01284569
What this trial is testing

Study to Assess Safety and Efficacy of Anti-Interleukin 6-receptor (IL6R) Nanobody in Rheumatoid Arthritis (RA) Patients

Who this might be right for
Rheumatoid Arthritis
Ablynx, a Sanofi company 65
Not applicableUnknownNCT04264494
What this trial is testing

Evaluating the Role of Intra-articular Injections of Platelet Rich Plasma (PRP) in Patients With Rheumatoid Arthritis.

Who this might be right for
RA - Rheumatoid Arthritis
Dalia Salah Saif 100
Testing effectiveness (Phase 2)Study completedNCT00280917
What this trial is testing

Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Can-Fite BioPharma 254
Post-approval studies (Phase 4)Study completedNCT00319917
What this trial is testing

A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients

Who this might be right for
Rheumatoid Arthritis
Astellas Pharma Inc 123
Not applicableStudy completedNCT02287610
What this trial is testing

A Non-Interventional Study of RAYOS in Adult Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Amgen 75
Not applicableStudy completedNCT01722617
What this trial is testing

Validate Questionnaires FLARE and OM-RA-FLARE Measuring Disease Flares in Patients With Rheumatoid Arthritis.

Who this might be right for
Arthritis, Rheumatoid
Central Hospital, Nancy, France 207
Testing effectiveness (Phase 2)Ended earlyNCT00808210
What this trial is testing

Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab

Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 28
Not applicableStudy completedNCT01768923
What this trial is testing

Early RA Vascular Randomised Controlled Study

Who this might be right for
Early Rheumatoid Arthritis
Chinese University of Hong Kong 120
Not applicableStudy completedNCT02234960
What this trial is testing

Local, Non-Interventional Study of RoActemra (Tocilizumab) in Poland (ACT-POL): First-Line Treatment in Routine Clinical Practice of Participants With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 102
Early research (Phase 1)Ended earlyNCT02481180
What this trial is testing

Tolerance, Pharmacokinetics and Preliminary Efficacy of T0001 in RA (Rheumatoid Arthritis)

Who this might be right for
Rheumatoid Arthritis
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 36
Post-approval studies (Phase 4)Study completedNCT01500278
What this trial is testing

Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate

Who this might be right for
Rheumatoid Arthritis
UCB Pharma SA 915
Testing effectiveness (Phase 2)Ended earlyNCT03823378
What this trial is testing

A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in Combination With Upadacitinib

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 97
Not applicableLooking for participantsNCT07484243
What this trial is testing

Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)Rheumatoid Arthritis-Associated Interstitial Lung DiseaseDifficult-to-Treat Rheumatoid Arthritis
Dongyi He 10,000
Not applicableStudy completedNCT03953378
What this trial is testing

CD73+ Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis

Who this might be right for
Rheumatoid ArthritisPsoriatic Arthritis
Hospices Civils de Lyon 41
Very early researchLooking for participantsNCT06888960
What this trial is testing

Safety Study of CC312 in Autoimmune Disease Patients

Who this might be right for
Systemic Lupus Erythematosus (SLE)Idiopathic Inflammatory Myopathy (IIM)Systemic Sclerosis (SSc)+3 more
CytoCares Inc 18
Large-scale testing (Phase 3)Study completedNCT02715908
What this trial is testing

Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active RA Despite Methotrexate (MTX)

Who this might be right for
Rheumatoid Arthritis
LG Life Sciences 148
Testing effectiveness (Phase 2)Study completedNCT00462150
What this trial is testing

Effects of Home-Based Emotional Disclosure in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
UMC Utrecht 80
Not applicableNot Yet RecruitingNCT07153315
What this trial is testing

AI-Based Medical Data Analysis for Differentiating Inflammatory vs Degenerative Joint Diseases in Elderly Patients

Who this might be right for
Arthritis, Rheumatoid (RA)
Assiut University 140
Next Page